ChiCTR1800014885
尚未开始
/
/
/
2018-02-12
/
/
超重或肥胖
An educational program for Hong Kong Chinese post-menopausal women
A theory-based educational program to improve the cardiovascular health among Hong Kong Chinese post-menopausal women
1) To examine the effects of the educational intervention on knowledge of CV health, self-efficacy and exercise, and physical activity and dietary pattern; 2) To examine if the effects of the intervention on physical activity and dietary pattern are mediated through knowledge of CV health, and self-efficacy in diet and exercise; 3) To examine if a positive change in physical activity and dietary pattern can result in improvements on CV health outcomes (body weight, body fat mass percentage, WC, CVD risk, fasting blood glucose, lipid profile, high sensitivity CRP, adiponectin, and IGF-1), sleep quality and vasomotor symptoms among overweight Chinese post-menopausal women in Hong Kong.
随机平行对照
其它
After collecting baseline data, eligible participants will be randomly allocated to intervention or control group using a computer-generated random number sequence prepared by an independent statistician.
The research assistant responsible for data collection will be blinded for group allocations of participants.
General Research Fund, Hong Kong
/
144
/
2018-01-01
2020-08-31
/
1) Chinese post-menopausal women aged ≤65 years [post-menopause is defined as experience of amenorrhea not attributing to other causes for at least 12 months13]; 2) Being overweight or obese (BMI > 22.9 kg/m2) or with central obesity (WC > 80cm)41; 3) Able to give informed consent; 4) Attain at least 6 years of formal education.；
请登录查看1) Being diagnosed with any cardiovascular disease; 2) Concurrently participating in another clinical trial, lifestyle/dietary intervention, or weight control program; 3) Concurrently using hormonal replacement therapy; 4) Known history of psychiatric disorders.；
请登录查看香港中文大學那打素護理學院
/
赛德特生物2026-05-13
药物信息2026-05-13
恒瑞医药2026-05-13
嘉应制药2026-05-13
罕见病信息网2026-05-13
抗体圈2026-05-13
同写意2026-05-13
数字医疗2026-05-13
GLP1减重宝典2026-05-13
科伦博泰生物2026-05-13
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
